Compulsory Psychotropic Medication in the California State Prison System

Area of Science:

• Legal Studies
• Medical Ethics
• Public Health Policy

Background:

• The U.S. Supreme Court in Washington v. Harper mandated administrative review for compulsory antipsychotic medication.
• California's historical context includes 'civil death' (1850) and the Keyhea injunction (1986).
• Previous legal frameworks proved insufficient, necessitating new legislation.

Purpose of the Study:

• To trace the historical evolution of legal processes for administering antipsychotic medication in California prisons.
• To analyze California Penal Code section 2602 (PC2602) from legal-administrative and clinical viewpoints.
• To contextualize PC2602 within the framework established by Washington v. Harper.

Main Methods:

• Historical legal analysis tracing key court cases and legislation.
• Examination of California Penal Code section 2602.
• Review of legal-administrative and clinical perspectives on the current process.

Main Results:

• California's PC2602 establishes a judicial review process for both emergent and nonemergent antipsychotic medication.
• This process evolved from historical precedents including 'civil death' and the Keyhea injunction.
• PC2602 represents a legislative response to address deficiencies in prior due process models.

Conclusions:

• PC2602 provides a judicial review framework for compulsory antipsychotic medication in California prisons.
• The law balances constitutional due process requirements with clinical and administrative needs.
• Understanding the historical trajectory is crucial for evaluating the current legal landscape of mental health treatment in corrections.